TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,467,760 | +12.6% | 203,632 | +100.0% | 0.01% | -33.3% |
| Q4 2021 | $4,857,000 | -27.3% | 101,815 | +1.2% | 0.01% | -36.8% |
| Q3 2021 | $6,683,000 | -55.8% | 100,598 | -48.1% | 0.02% | -13.6% |
| Q2 2021 | $15,120,000 | +96.1% | 193,792 | +137.8% | 0.02% | -4.3% |
| Q1 2021 | $7,710,000 | -20.9% | 81,506 | +1.9% | 0.02% | -25.8% |
| Q4 2020 | $9,748,000 | +22.0% | 79,996 | -12.5% | 0.03% | +6.9% |
| Q3 2020 | $7,990,000 | -53.0% | 91,466 | -65.3% | 0.03% | -14.7% |
| Q2 2020 | $17,002,000 | +31.8% | 263,234 | -8.9% | 0.03% | +6.2% |
| Q1 2020 | $12,900,000 | -32.1% | 288,852 | -5.3% | 0.03% | -17.9% |
| Q4 2019 | $19,008,000 | – | 305,138 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |